05:16 PM EDT, 06/03/2025 (MT Newswires) -- Cyclacel Pharmaceuticals ( CYCC ) said late Tuesday it has regained compliance with Nasdaq's minimum bid price requirement.
The biopharmaceutical company said it received notification from Nasdaq stating the matter is now closed.
Shares of the company were up more than 2% in after-hours activity.